Armstrong SA - Search Results

1

Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation.

Ferrando AA, Armstrong SA, Neuberg DS, Sallan SE, Silverman LB, Korsmeyer SJ, Look AT. Ferrando AA, et al. Among authors: armstrong sa. Blood. 2003 Jul 1;102(1):262-8. doi: 10.1182/blood-2002-10-3221. Epub 2003 Mar 13. Blood. 2003. PMID: 12637319 Free article.

2

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.

Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ. Armstrong SA, et al. Nat Genet. 2002 Jan;30(1):41-7. doi: 10.1038/ng765. Epub 2001 Dec 3. Nat Genet. 2002. PMID: 11731795

3

Genomic approaches to the pathogenesis and treatment of acute lymphoblastic leukemias.

Armstrong SA, Hsieh JJ, Korsmeyer SJ. Armstrong SA, et al. Curr Opin Hematol. 2002 Jul;9(4):339-44. doi: 10.1097/00062752-200207000-00012. Curr Opin Hematol. 2002. PMID: 12042709 Review.

4

Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia.

Stam RW, den Boer ML, Meijerink JP, Ebus ME, Peters GJ, Noordhuis P, Janka-Schaub GE, Armstrong SA, Korsmeyer SJ, Pieters R. Stam RW, et al. Among authors: armstrong sa. Blood. 2003 Feb 15;101(4):1270-6. doi: 10.1182/blood-2002-05-1600. Epub 2002 Oct 24. Blood. 2003. PMID: 12406912 Free article.

5

Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.

Armstrong SA, Kung AL, Mabon ME, Silverman LB, Stam RW, Den Boer ML, Pieters R, Kersey JH, Sallan SE, Fletcher JA, Golub TR, Griffin JD, Korsmeyer SJ. Armstrong SA, et al. Cancer Cell. 2003 Feb;3(2):173-83. doi: 10.1016/s1535-6108(03)00003-5. Cancer Cell. 2003. PMID: 12620411 Free article.

6

Comparison of human genomics and genetic models of cancer to identify novel therapeutic targets.

Armstrong SA, Korsmeyer SJ. Armstrong SA, et al. Cell Cycle. 2003 Sep-Oct;2(5):408-9. Cell Cycle. 2003. PMID: 12963826 Review. No abstract available.

7

MLL-rearranged leukemias: insights from gene expression profiling.

Armstrong SA, Golub TR, Korsmeyer SJ. Armstrong SA, et al. Semin Hematol. 2003 Oct;40(4):268-73. doi: 10.1016/s0037-1963(03)00196-3. Semin Hematol. 2003. PMID: 14582077 Review.

8

FLT3 mutations in childhood acute lymphoblastic leukemia.

Armstrong SA, Mabon ME, Silverman LB, Li A, Gribben JG, Fox EA, Sallan SE, Korsmeyer SJ. Armstrong SA, et al. Blood. 2004 May 1;103(9):3544-6. doi: 10.1182/blood-2003-07-2441. Epub 2003 Dec 11. Blood. 2004. PMID: 14670924 Free article.

9

Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease.

Wang J, Iwasaki H, Krivtsov A, Febbo PG, Thorner AR, Ernst P, Anastasiadou E, Kutok JL, Kogan SC, Zinkel SS, Fisher JK, Hess JL, Golub TR, Armstrong SA, Akashi K, Korsmeyer SJ. Wang J, et al. Among authors: armstrong sa. EMBO J. 2005 Jan 26;24(2):368-81. doi: 10.1038/sj.emboj.7600521. Epub 2005 Jan 6. EMBO J. 2005. PMID: 15635450 Free PMC article.

10

Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia.

Stam RW, den Boer ML, Schneider P, Nollau P, Horstmann M, Beverloo HB, van der Voort E, Valsecchi MG, de Lorenzo P, Sallan SE, Armstrong SA, Pieters R. Stam RW, et al. Among authors: armstrong sa. Blood. 2005 Oct 1;106(7):2484-90. doi: 10.1182/blood-2004-09-3667. Epub 2005 Jun 14. Blood. 2005. PMID: 15956279 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters